Biomarkers and Inflammation in Solid Organ Transplantation: Relationship With Short- and Long-Term Outcomes

Recruiting now

Conditions studied: Solid Organ Transplantation

In brief

This is a prospective, tissue-based, low-risk, non-pharmacological study that will include adult patients undergoing solid organ transplantation (heart, liver, lung, kidney) followed at the following Units of the IRCCS Azienda Ospedaliero-Universitaria di Bologna (IRCCS AOUBO): * Heart Failure and Transplants (heart-lung) * Internal Medicine for the Treatment of Severe Organ Failures (liver) * Nephrology, Dialysis, and Transplantation (kidney).

Key facts

Study ID

NCT06774339

Run by

IRCCS Azienda Ospedaliero-Universitaria di Bologna

People needed

250

Starts

2024-10-10

Expected to finish

2031-12-01

Last updated by the study team

2025-01-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients (≥ 18 years old at the time of enrollment) who have undergone at least one of the following: Liver transplant, Kidney transplant, Heart transplant, Lung transplant during the study period.
• Informed consent acquisition.

You may not qualify if…

• none

Where it is running

• IRCCS - Azienda ospedaliero-universitaria di Bologna — Bologna, Italy (enrolling)
• IRCCS - Azienda ospedaliero-universitaria di Bologna — Bologna, Italy (enrolling)
• IRCCS - Azienda ospedaliero-universitaria di Bologna — Bologna, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.